Press Releases

Year

Nov 2012

LifeVantage Makes a Donation to the Against Malaria Foundation

Thousands in Sub-Saharan Africa Benefit From Its Giving Program

PDF Version

Nov 2012

LifeVantage Announces Strong First Quarter Fiscal Year 2013 Results

First Quarter Net Revenue Increases 163% Over Prior Year Period to $52.9 Million First Quarter Operating Income Improves to $6.9 Million Company Reiterates Full Year Fiscal 2013 Revenue, Operating Margin, and Earnings Per Share Guidance Expands Japanese Operations With Opening of Tokyo Office SALT

PDF Version

Nov 2012

LifeVantage to Announce Fiscal First Quarter 2013 Results on November 8, 2012

SALT LAKE CITY , Nov. 1, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement Protandim

PDF Version

Oct 2012

LifeVantage Corporation Announces Appointment of Head of Asia Operations

Company Appoints David Toda as New President and Managing Director, Asia Pacific

PDF Version

Oct 2012

LifeVantage Appoints Darlene R. Walley Ph.D. as New Chief Science Officer

Company Expands Research and Product Development for Future Growth Opportunities

PDF Version

Sep 2012

LifeVantage Announces Continued International Expansion

SALT LAKE CITY , Sept. 19, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement Protandim ® ,

PDF Version

Sep 2012

LifeVantage to Present at the Imperial Capital Global Opportunities Conference

SALT LAKE CITY , Sept. 13, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement

PDF Version

Sep 2012

LifeVantage Corporation Receives Approval to List on the NASDAQ Capital Market

SALT LAKE CITY , Sept. 10, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement

PDF Version

Sep 2012

LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results

Company Receives Approval to List on The Nasdaq Capital Market Fourth Quarter Net Revenue Increases 197% Over Prior Year Period to $44.6 Million Fourth Quarter Operating Income Improves to a Record $7.3 Million Company Issues Full Year Fiscal 2013 Revenue, Operating Margin, and Earning Per Share

PDF Version

Aug 2012

LifeVantage to Announce Fiscal Fourth Quarter and Full Year 2012 Results on September 10, 2012

SALT LAKE CITY , Aug. 31, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, announced today it will release financial results for its fourth fiscal quarter and full year ended June

PDF Version

Pagination

First page
Previous page
…
Page 27
Page 28
Page 29
Page 30
Current page 31
Page 32
Page 33
Page 34
Page 35
…
Next page
Last page